The major cause of chemotherapy failure in patients with chronic gastritis and peptic ulcers caused by Helicobacter pylori is clarithromycin (CAM) resistance due to a mutation in the 23S rRNA gene. This study describes a non-invasive and accurate method for the detection of mixed CAM-resistant and -susceptible H. pylori by sequencing of the H. pylori 23S rRNA gene. Faeces were crushed with beads and the 23S rRNA gene was amplified using a nested PCR on the extracted DNA. Mutation analysis of this gene using this method showed that 20.4 % of patients carried mixed CAM-susceptible (wild type) and -resistant (A2142G or A2143G mutant) H. pylori. Furthermore, it was found that 66.6 % of patients who had been treated unsuccessfully carried one of these mutations in the 23S rRNA gene (including the mixed type), whilst standard culture detected CAM-resistant isolates in only 22.2 % of patients with unsuccessful treatment. These data suggest that, for successful therapy, the diagnosis method described here would more accurately detect CAM-resistant H. pylori, including mixed infections.
AlarconT.,
VegaA. E.,
DomingoD.,
MartinezM. J.,
Lopez-BreaM.2003; Clarithromycin resistance among Helicobacter pylori strains isolated from children: prevalence and study of mechanism of resistance by PCR-restriction fragment length polymorphism analysis. J Clin Microbiol 41:486–499[CrossRef]
FontanaC.,
FavaroM.,
MinelliS.,
CriscuoloA. A.,
PietroiustiA.,
GalanteA.,
FavalliC.2002; New site of modification of 23S rRNA associated with clarithromycin resistance of Helicobacter pylori clinical isolates. Antimicrob Agents Chemother 46:3765–3769[CrossRef]
FurutaT.,
ShiraiN.,
TakashimaM.,
XiaoF.,
HanaiH.,
SugimuraH.,
OhashiK.,
IshizakiT.,
KanekoE.2001; Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin. Clin Pharmacol Ther 69:158–168[CrossRef]
GoodwinC. S.,
BlincowE. D.,
WarrenJ. R.,
WatersT. E.,
SandersonC. R.,
EastonL.1985; Evaluation of cultural techniques for isolating Campylobacter pyloridis from endoscopic biopsies of gastric mucosa. J Clin Pathol 38:1127–1131[CrossRef]
ItoM.,
TanakaS.,
KimS.,
TaharaK.,
KawamuraY.,
SumiiM.,
TakeharaY.,
HayashiK.,
OkamotoE.other authors2005; A combination of the Helicobacter pylori stool antigen test and urea breath test is useful for clinical evaluation of eradication therapy: a multicenter study. J Gastroenterol Hepatol 20:1241–1245[CrossRef]
KhanR.,
NaharS.,
SultanaJ.,
AhmadM. M.,
RahmanM.2004; T2182C mutation in 23S rRNA is associated with clarithromycin resistance in Helicobacter pylori isolates obtained in Bangladesh. Antimicrob Agents Chemother 48:3567–3569[CrossRef]
KimJ. M.,
KimJ. S.,
KimN.,
KimS. G.,
JungH. C.,
SongI. S.2006; Comparison of primary and secondary antimicrobial minimum inhibitory concentrations for Helicobacter pylori isolated from Korean patients. Int J Antimicrob Agents 28:6–13[CrossRef]
KustersJ. G.,
GerritsM. M.,
Van StrijpJ. A.,
Vandenbroucke-GraulsC. M.1997; Coccoid forms of Helicobacter pylori are the morphologic manifestation of cell death. Infect Immun 65:3672–3679
LeodolterA.,
VairaD.,
BazzoliF.,
SchutzeK.,
HirschlA.,
MegraudF.,
MalfertheinerP.2003; European multicentre validation trial of two new non-invasive tests for the detection of Helicobacter pylori antibodies: urine-based ELISA and rapid urine test. Aliment Pharmacol Ther 18:927–931[CrossRef]
MatsukiT.,
WatanabeK.,
FujimotoJ.,
KadoY.,
TakadaT.,
MatsumotoK.,
TanakaR.2004; Quantitative PCR with 16S rRNA-gene-targeted species-specific primers for analysis of human intestinal bifidobacteria. Appl Environ Microbiol 70:167–173[CrossRef]
McOristA. L.,
JacksonM.,
BirdA. R.2002; A comparison of five methods for extraction of bacterial DNA from human faecal samples. J Microbiol Methods 50:131–139[CrossRef]
MonteiroL.,
GrasN.,
VidalR.,
CabritaJ.,
MegraudF.2001; Detection of Helicobacter pylori DNA in human feces by PCR: DNA stability and removal of inhibitors. J Microbiol Methods 45:89–94[CrossRef]
MorrisJ. M.,
ReasonoverA. L.,
BruceM. G.,
BrudenD. L.,
McMahonB. J.,
SaccoF. D.,
BergD. E.,
ParkinsonA. J.2005; Evaluation of seaFAST, a rapid fluorescent in situ hybridization test, for detection of Helicobacter pylori and resistance to clarithromycin in paraffin-embedded biopsy sections. J Clin Microbiol 43:3494–3496[CrossRef]
NurgalievaZ. Z.,
OpekunA. R.,
GrahamD. Y.2006; Problem of distinguishing false-positive tests from acute or transient Helicobacter pylori infections. Helicobacter 11:69–74[CrossRef]
ProkhorenkoI. A.,
MalakhovA. D.,
KozlovaA. A.,
MomynalievK.,
GovorunV. M.,
KorshunV. A.2006; Phenylethynylpyrene-labeled oligonucleotide probes for excimer fluorescence SNP analysis of 23S rRNA gene in clarithromycin-resistant Helicobacter pylori strains. Mutat Res 599:144–151[CrossRef]
RimbaraE.,
NoguchiN.,
TanabeM.,
KawaiT.,
MatsumotoY.,
SasatsuM.2005a; Susceptibilities to clarithromycin, amoxycillin and metronidazole of Helicobacter pylori isolates from the antrum and corpus in Tokyo, Japan, 1995–2001. Clin Microbiol Infect 11:307–311[CrossRef]
RimbaraE.,
NoguchiN.,
YamaguchiT.,
NaruiK.,
KawaiT.,
SasatsuM.2005b; Development of a highly sensitive method for detection of clarithromycin-resistant Helicobacter pylori from human feces. Curr Microbiol 51:1–5[CrossRef]
ToracchioS.,
AcetoG. M.,
Mariani-CostantiniR.,
BattistaP.,
MarzioL.2004; Identification of a novel mutation affecting domain V of the 23S rRNA gene in Helicobacter pylori
. Helicobacter 9:396–399[CrossRef]
VairaD.,
MalfertheinerP.,
MegraudF.,
AxonA. T.,
DeltenreM.,
HirschlA. M.,
GasbarriniG.,
O'MorainC.,
GarciaJ. M.other authors1999; Diagnosis of Helicobacter pylori infection with a new non-invasive antigen-based assay. HpSA European study group. Lancet 354:30–33[CrossRef]
van DoornL. J.,
GlupczynskiY.,
KustersJ. G.,
MégraudF.,
MidoloP.,
Maggi-SolcàN.,
QueirozD. M.,
NouhanN.,
StetE.,
QuintW. G.2001; Accurate prediction of macrolide resistance in Helicobacter pylori by a PCR line probe assay for detection of mutations in the 23S rRNA gene: multicenter validation study. Antimicrob Agents Chemother 45:1500–1504[CrossRef]
WongB. C.,
WangW. H.,
BergD. E.,
FungF. M.,
WongK. W.,
WongW. M.,
LaiK. C.,
ChoC. H.,
HuiW. M.,
LamS. K.2001; High prevalence of mixed infections by Helicobacter pylori in Hong Kong: metronidazole sensitivity and overall genotype. Aliment Pharmacol Ther 15:493–503[CrossRef]